HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Angelo Paolo Dei Tos Selected Research

Phosphotransferases (Kinase)

1/2021Protein Kinase CK1α Sustains B-Cell Receptor Signaling in Mantle Cell Lymphoma.
7/2009The VEGF-system in primary pulmonary angiosarcomas and haemangioendotheliomas: new potential therapeutic targets?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Angelo Paolo Dei Tos Research Topics

Disease

33Neoplasms (Cancer)
01/2022 - 06/2007
25Sarcoma (Soft Tissue Sarcoma)
01/2022 - 09/2010
11Neoplasm Metastasis (Metastasis)
01/2022 - 01/2011
8Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 05/2015
4Liposarcoma
03/2021 - 09/2010
4Leiomyosarcoma
07/2017 - 09/2010
3Melanoma (Melanoma, Malignant)
05/2022 - 01/2021
3Synovial Sarcoma (Synovioma)
03/2022 - 09/2010
3Microsatellite Instability
01/2022 - 11/2019
3Osteosarcoma (Osteogenic Sarcoma)
09/2021 - 01/2015
3Disease Progression
01/2021 - 01/2013
3Squamous Cell Carcinoma of Head and Neck
01/2021 - 01/2017
3Neutropenia
01/2019 - 01/2017
3Hemangiosarcoma (Angiosarcoma)
07/2017 - 07/2009
3Myxoid Liposarcoma
01/2017 - 07/2009
2Margins of Excision
03/2022 - 10/2020
2Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 07/2009
2Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2022 - 07/2017
2Carcinoma (Carcinomatosis)
01/2022 - 09/2013
2Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2022 - 02/2021
2Adenocarcinoma
10/2021 - 01/2020
2Chondroblastoma
09/2021 - 10/2017
2Ewing Sarcoma (Sarcoma, Ewing)
06/2021 - 01/2021
2Breast Neoplasms (Breast Cancer)
01/2021 - 11/2012
2Adenosarcoma
11/2020 - 01/2018
2Adenoma (Adenomas)
01/2020 - 09/2013
2Carcinogenesis
01/2020 - 11/2012
2Hypertension (High Blood Pressure)
01/2019 - 05/2012
2Thrombocytopenia (Thrombopenia)
10/2018 - 01/2017
2Peripheral Nervous System Diseases (PNS Diseases)
01/2018 - 01/2014
2Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2018 - 01/2011
2Type 2 Diabetes Mellitus (MODY)
01/2018 - 01/2014
2Diabetic Foot
01/2018 - 01/2014
2Giant Cell Tumor of Bone
10/2017 - 01/2016
2Cysts
08/2008 - 02/2007
1Skin Neoplasms (Skin Cancer)
05/2022
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022
1Primary Myelofibrosis (Myelosclerosis)
01/2022
1Cholangiocarcinoma
01/2022
1COVID-19
01/2022
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2022
1Papillary Thyroid Cancer
01/2022
1Triploidy
12/2021
1Stomach Neoplasms (Stomach Cancer)
10/2021
1Osteoblastoma
09/2021
1Lung Neoplasms (Lung Cancer)
06/2021
1Bone Neoplasms (Bone Cancer)
06/2021
1Lung Diseases (Lung Disease)
06/2021

Drug/Important Bio-Agent (IBA)

8IfosfamideFDA LinkGeneric
12/2021 - 12/2011
6Proteins (Proteins, Gene)FDA Link
01/2022 - 09/2010
5Biological ProductsIBA
01/2022 - 01/2011
5TrabectedinIBA
03/2021 - 12/2011
4Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2017
4GemcitabineFDA Link
01/2020 - 01/2017
4Tyrosine Kinase InhibitorsIBA
01/2018 - 05/2012
4Imatinib Mesylate (Gleevec)FDA Link
01/2018 - 03/2012
3AntibodiesIBA
03/2022 - 06/2007
3RNA (Ribonucleic Acid)IBA
01/2022 - 01/2020
3AnthracyclinesIBA
12/2021 - 12/2011
3Protein Isoforms (Isoforms)IBA
10/2021 - 10/2013
3Immune Checkpoint InhibitorsIBA
05/2021 - 11/2019
3Hormones (Hormone)IBA
01/2021 - 01/2019
3Dacarbazine (DIC)FDA LinkGeneric
01/2020 - 01/2013
3Aquaporin 1IBA
07/2010 - 01/2006
2Inosine Triphosphate (ITP)IBA
01/2022 - 02/2021
2DNA (Deoxyribonucleic Acid)IBA
01/2022 - 12/2021
2CateninsIBA
09/2021 - 01/2021
2Doxorubicin (Adriamycin)FDA LinkGeneric
03/2021 - 07/2019
2Phosphotransferases (Kinase)IBA
01/2021 - 07/2009
2Anaplastic Lymphoma KinaseIBA
11/2020 - 07/2016
2Docetaxel (Taxotere)FDA Link
01/2020 - 01/2017
2Vascular Endothelial Growth Factor CIBA
01/2020 - 07/2009
2Etoposide (VP 16)FDA LinkGeneric
01/2020 - 01/2017
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 07/2009
2Alanine Transaminase (SGPT)IBA
01/2019 - 10/2018
2Sunitinib (Sutent)FDA Link
06/2018 - 01/2018
2Epirubicin (Ellence)FDA LinkGeneric
01/2018 - 01/2017
2Coloring Agents (Dyes)IBA
09/2013 - 06/2007
2Aquaporins (Water Channels)IBA
02/2007 - 01/2006
1Vitamin DFDA LinkGeneric
05/2022
1Formaldehyde (Formol)FDA Link
01/2022
1ParaffinIBA
01/2022
1Thrombopoietin ReceptorsIBA
01/2022
1Surface-Active Agents (Surfactants)IBA
01/2022
1MicroRNAs (MicroRNA)IBA
01/2022
1Protein CIBA
01/2022
1AZD 6244IBA
12/2021
1nilotinibFDA Link
12/2021
1avapritinibIBA
12/2021
1multidrug resistance-associated protein 1IBA
12/2021
1ripretinibIBA
12/2021
1Tight Junction ProteinsIBA
10/2021
1Somatostatin Receptors (Somatostatin Receptor)IBA
10/2021
1beta CateninIBA
09/2021

Therapy/Procedure

16Drug Therapy (Chemotherapy)
01/2022 - 07/2009
15Therapeutics
01/2022 - 09/2008
11Radiotherapy
03/2022 - 12/2012
4Neoadjuvant Therapy
01/2022 - 01/2017
2Adjuvant Chemotherapy
01/2015 - 03/2012
1Thymectomy
08/2021